Compare BSX & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSX | UBS |
|---|---|---|
| Founded | 1979 | 1862 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.7B | 120.6B |
| IPO Year | 1992 | N/A |
| Metric | BSX | UBS |
|---|---|---|
| Price | $97.46 | $40.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 3 |
| Target Price | ★ $124.53 | N/A |
| AVG Volume (30 Days) | ★ 8.9M | 1.8M |
| Earning Date | 10-22-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 1.83% |
| EPS Growth | 54.68 | ★ 84.33 |
| EPS | 1.87 | ★ 2.21 |
| Revenue | $19,349,000,000.00 | ★ $48,193,000,000.00 |
| Revenue This Year | $21.05 | $4.87 |
| Revenue Next Year | $11.43 | $3.54 |
| P/E Ratio | $52.15 | ★ $17.47 |
| Revenue Growth | ★ 21.61 | 2.09 |
| 52 Week Low | $85.98 | $25.75 |
| 52 Week High | $109.50 | $42.57 |
| Indicator | BSX | UBS |
|---|---|---|
| Relative Strength Index (RSI) | 41.77 | 66.47 |
| Support Level | $100.50 | $38.33 |
| Resistance Level | $101.91 | $38.27 |
| Average True Range (ATR) | 2.03 | 0.57 |
| MACD | -0.30 | 0.29 |
| Stochastic Oscillator | 19.87 | 96.66 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.